AVCT:LSE Avacta Group PLC

GBX 70.50 2.00 2.919708
Icon

Avacta Group PLC (AVCT:LSE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 70.50

+2.00 (+2.92)%

GBX 0.26B

1.30M

N/A

N/A

Icon

AVCT:LSE

Avacta Group PLC (GBX)
COMMON STOCK | LSE
GBX 70.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 0.26B

N/A

GBX 70.50

Avacta Group PLC (AVCT:LSE) Stock Forecast

N/A

Based on the Avacta Group PLC stock forecast from 0 analysts, the average analyst target price for Avacta Group PLC is not available over the next 12 months. Avacta Group PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Avacta Group PLC is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Avacta Group PLC’s stock price was GBX 70.50. Avacta Group PLC’s stock price has changed by +8.46% over the past week, +57.54% over the past month and -27.32% over the last year.

No recent analyst target price found for Avacta Group PLC
No recent average analyst rating found for Avacta Group PLC

Company Overview Avacta Group PLC

Avacta Group Plc develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally. The company operates through Diagnostics and Therapeutics segments. It provides its proprietary Affimer and pre|CISION t...Read More

https://www.avacta.com

Thorp Arch Estate, Wetherby, United Kingdom, LS23 7FA

154

December

GBX

UK

Adjusted Closing Price for Avacta Group PLC (AVCT:LSE)

Loading...

Unadjusted Closing Price for Avacta Group PLC (AVCT:LSE)

Loading...

Share Trading Volume for Avacta Group PLC Shares

Loading...

Compare Performance of Avacta Group PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AVCT:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Avacta Group PLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GNS:LSE
Genus PLC +50.00 (+3.05%) GBX1.25B 37.06 13.84

ETFs Containing AVCT

Symbol Name AVCT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Avacta Group PLC (AVCT:LSE) Stock

Stock Target Advisor's fundamental analysis for Avacta Group PLC's stock is Slightly Bearish.

Unfortunately we do not have enough data on AVCT:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on AVCT:LSE's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on AVCT:LSE's stock to indicate if its overvalued.

The last closing price of AVCT:LSE's stock was GBX 70.50.

The most recent market capitalization for AVCT:LSE is GBX 0.26B.

Unfortunately we do not have enough analyst data on AVCT:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Avacta Group PLC's stock.

As per our most recent records Avacta Group PLC has 154 Employees.

Avacta Group PLC's registered address is Thorp Arch Estate, Wetherby, United Kingdom, LS23 7FA. You can get more information about it from Avacta Group PLC's website at https://www.avacta.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...